Nutriband Raised $1.75M Through Warrant Exercise
The Orlando-based company has converted all remaining tradeable warrants into equity to fund ongoing drug development.
Live Poll
Do you trust small-cap pharmaceutical companies to successfully bring experimental new drug technologies to market?
